Company intelligence / Profile preview

Ind-Swift

Chandigarh, Chandigarh, India

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

Ind-Swift manufactures and markets over 750 pharmaceutical and herbal products across major therapeutic areas, with an active portfolio of finished dosage forms and APIs, and exports to 45 countries. Notable achievements include US/EU patents for extended release clarithromycin.

Therapeutic areas: ImmunologyEndocrinologyPsychiatryInfectious DiseasesCardiovascularOncologyNeurology
Modalities: Small moleculeHerbal drugFormulation
Industry: Biotech

Beyond the preview

Go deeper on Ind-Swift.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ind-Swift.

Explore the full profile